Rapid, quantitative human lymphocyte separation and purification in a closed system.

A. Luderer,A. Zine,D. Hess,J. N. Henyan,G. Odstrchel

DOI: https://doi.org/10.1016/0161-5890(79)90125-1

IF: 4.174

1979-08-01

Molecular Immunology

Abstract:

What problem does this paper attempt to address?

Preparation and performance characterization of electrospun drug loaded poly (vinyl alcohol)/chitosan nanofibrous membrane

Yani ZHANG,Shanwei WU,Jiayao XU,Wei CHEN,Yuanyuan LV

DOI: https://doi.org/10.3785/j.issn.1008-9292.2013.06.009

2013-01-01

Abstract:To prepare nanofibrous membranes of poly (vinyl alcohol)/chitosan (PVA/CS) loaded with varied salvianic acid A sodium (SAS) contents.Ultrafine fiber mats were prepared with PVA/CS as matrix and SAS as model drug. The structure and morphology of the nanofibrous membranes were characterized by FT-IR and SEM. Drug-loading amount and drug release profiles of these membranes were determined by UV VIS spectra, and the degradation of the membranes was also investigated.Average diameters of PVA/CS/SAS nanofibers with different SAS contents were 280 ≊390 nm. Drug-loading amount of these nanofibrous membranes was high and exhibited sustained and controlled release behavior for SAS.The PVA/CS/SAS nanofibrous membrane prepared in this study loads drug uniformly and has remarkably sustained release behavior, which may offer strategies for the research and development of novel topical drug delivery systems.
A Chitosan/gelatin/aldehyde Hyaluronic Acid Hydrogel Coating Releasing Calcium Ions and Vancomycin in Ph Response to Prevent the Formation of Bacterial Biofilm

Yuange Li,Hong Sung Min,Chen,Haojie Shan,Yiwei Lin,Fuli Yin,Yixian Chen,Liheng Lu,Xiaowei Yu

DOI: https://doi.org/10.1016/j.carbpol.2024.122723

IF: 10.723

2025-01-01

Carbohydrate Polymers

Abstract:Osteomyelitis is a refractory disease of orthopedics, part of which is caused by medical implants. The main difficulties in treatment are the barrier effect after the formation of bacterial biofilm, and the difficulty in achieving sustained antibiotic intervention. In view of this situation, we studied a hydrogel coating that can release CaCl2 and vancomycin in pH-responsive manner. We used nano-TiO2 to modify Chitosan/ Gelatin/Aldehyde Hyaluronic Acid (CS/Gel/AHA) hydrogel, and combined with the dip-coating technique, prepared a coating with good mechanical strength. The hydrogel-loaded zeolitic imidazolate framework (ZIF) decomposes under acidic conditions, and the released Ca2+ act on the bacterial Bap protein to inhibit the formation of biofilm, and the released vancomycin kills free bacteria. The antibacterial coating achieved good bactericidal effect in both in vitro experiments and rat subcutaneous implant model. These results not only provide a new way to enhance the strength of hydrogels to prepare coatings, but also utilize a new approach to responsively inhibit the formation of biofilms, showing the promising application prospects of the coating in antibacterial treatment of medical implants.
Silk coating on poly(ε-caprolactone) microspheres for the delayed release of vancomycin.

Jian Zhou,TaoLin Fang,Jianchuan Wen,Zhengzhong Shao,Jian Dong

DOI: https://doi.org/10.3109/02652048.2010.534824

2011-01-01

Journal of Microencapsulation

Abstract:The treatment of osteomyelitis remains a challenge for orthopaedic surgeons. Controlled release of vancomycin from biodegradable microspheres is a promising method for eliminating infection. However, the large initial burst release may make it difficult to maintain the local vancomycin concentration superior to minimum inhibitory concentration for several weeks. The aims of this study were to explore applications of the silk fibroin (SF) as an aqueous coating material for vancomycin-loaded poly(epsilon epsilon-caprolactone) (PCL) microspheres, and investigate the effects of silk coating on in vitro drug release. Examinations of particle size analyses, vancomycin content, Fourier transform infrared spectroscopy, differential scanning calorimetry, scanning electron microscopy and in vitro drug release were performed. The results showed that silk coating could reduce the large initial burst release and retard the vancomycin release. Therefore, we suggest that the SF could be used as an aqueous coating material for vancomycin-loaded PCL microspheres and prolonged the drug release. SF coating on vancomycin-loaded PCL microspheres may be considered as an effective approach to prolong the drug release and improve the anti-infection effects.</.
Recurrent staphylococcal infection in a pediatric residential care facility.

R. Steele,E. Ashcraft,T. Payton,K. Eisenach

DOI: https://doi.org/10.1016/0196-6553(83)90003-2

IF: 4.303

1983-12-01

American Journal of Infection Control

Abstract:
In vitro drug release and antibacterial activity evaluation of silk fibroin coated vancomycin hydrochloride loaded poly (lactic-co-glycolic acid) (PLGA) sustained release microspheres

Shengtang Li,Xuewen Shi,Bo Xu,Jian Wang,Peng Li,Xin Wang,Jinpeng Lou,Ziyao Li,Chengwei Yang,Songkai Li,Ping Zhen

DOI: https://doi.org/10.1177/08853282211064098

2022-01-11

Journal of Biomaterials Applications

Abstract:Currently, the treatment of osteomyelitis poses a great challenge to clinical orthopedics. The use of biodegradable materials combined with antibiotics provides a completely new option for the treatment of osteomyelitis. In this study, vancomycin hydrochloride (VANCO) loaded poly (lactic-co-glycolic acid) (PLGA) microspheres were prepared by a double emulsion solvent evaporation method, and the in vitro drug release behaviors of the drug loaded microspheres were explored after coating with different concentrations of silk fibroin (SF). Drug loading, encapsulation efficiency, Scanning electron microscopy, particle size analysis, Fourier transform infrared spectroscopy, hydrophilicity, in vitro drug release, and in vitro antibacterial activity were evaluated. The results showed that the drug loading of vancomycin loaded PLGA microspheres was (24.11 ±1.72)%, and the encapsulation efficiency was (48.21 ±3.44)%. The in vitro drug release indicated that the drug loaded microspheres showed an obvious initial burst release, and the drug loaded microspheres coated with SF could alleviate the initial burst release in varying degrees. It also can reduce the amount of cumulative drug release, and the effect of microspheres coated with 0.1% concentration of SF is the best. The time of in vitro drug release in different groups of drug loaded microspheres can be up to 28 days. The microspheres coated with (0.1%SF) or without (0%SF) SF showed a cumulative release of (82.50±3.51)% and (67.70±3.81)%,respectively. Therefore, the surface coating with SF of vancomycin loaded microspheres can alleviate the initial burst release, reduce the cumulative drug release, potentially prolong the drug action time, and improve the anti-infection effect.

engineering, biomedical,materials science, biomaterials
Sustainable release of vancomycin, gentamicin and lidocaine from novel electrospun sandwich-structured PLGA/collagen nanofibrous membranes

Dave W Chen,Yung-Heng Hsu,Jun-Yi Liao,Shih-Jung Liu,Jan-Kan Chen,Steve Wen-Neng Ueng

DOI: https://doi.org/10.1016/j.ijpharm.2012.04.010

2012-07-01

Abstract:This study investigated the in vitro release of vancomycin, gentamicin, and lidocaine from novel electrospun sandwich-structured polylactide-polyglycolide (PLGA)/collagen nanofibrous membranes. For the electrospinning of biodegradable membranes, PLGA/collagen and PLGA/vancomycin/gentamicin/lidocaine were separately dissolved in 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP). They were then electrospun into sandwich structured membranes, with PLGA/collagen for the surface layers and PLGA/drugs for the core layer. After electrospinning, an elution method and HPLC assay were employed to characterize the in vitro release rates of the pharmaceutics over a 30-day period. The experiment showed that biodegradable nanofibrous membranes released high concentrations of vancomycin and gentamicin (well above the minimum inhibition concentration) for 4 and 3 weeks, respectively, and lidocaine for 2 weeks. A bacterial inhibition test was carried out to determine the relative activity of the released antibiotics. The bioactivity of vancomycin and gentamicin ranged from 30% to 100% and 37% to 100%, respectively. In addition, results indicated that the nanofibrous membranes were functionally active in responses in human fibroblasts. By adopting the electrospinning technique, we will be able to manufacture biodegradable biomimetic nanofibrous extracellular membranes for long-term drug delivery of various pharmaceuticals.
Controlled release of vancomycin from PEGylated fibrinogen polyethylene glycol diacrylate hydrogel

Duc-Viet Nguyen,Yunong Yuan,Marek Kukumberg,Lingxin Wang,Seng Han Lim,Ammar Mansoor Hassanbhai,Mark Chong,Theodoros Kofidis,Edwin C K Tan,Dror Seliktar,Lifeng Kang,Abdul Jalil Rufaihah

DOI: https://doi.org/10.1016/j.bioadv.2024.213896

Abstract:Surgical site infection (SSI) is a common issue post-surgery which often prolongs hospitalization and can lead to serious complications such as sternal wound infection following cardiac surgery via median sternotomy. Controlled release of suitable antibiotics could allow maximizing drug efficacy and safety, and therefore achieving a desired therapeutic response. In this study, we have developed a vancomycin laden PEGylated fibrinogen-polyethylene glycol diacrylate (PF-PEGDA) hydrogel system that can release vancomycin at a controlled and predictable rate to be applied in SSI prevention. Two configurations were developed to study effect of the hydrogel on drug release, namely, vancomycin laden hydrogel and vancomycin solution on top of blank hydrogel. The relationship between the rigidity of the hydrogel and drug diffusion was found to comply with a universal power law, i.e., softer hydrogels result in a greater diffusion coefficient hence faster release rate. Besides, vancomycin laden hydrogels exhibited burst release, whereas the vancomycin solution on top of blank hydrogels exhibited lag release. A mathematical model was developed to simulate vancomycin permeation through the hydrogels. The permeation of vancomycin can be predicted accurately by using the mathematical model, which provided a useful tool to customize drug loading, hydrogel thickness and stiffness for personalized medication to manage SSI. To evaluate the potential of hydrogels for bone healing applications in cardiovascular medicine, we performed a proof-of-concept median sternotomy in rabbits and applied the hydrogels. The hydrogel formulations accelerated the onset of osteo-genetic processes in rabbits, demonstrating its potential to be used in human.
Innovative Vancomycin-Loaded Hydrogel-Based Systems - New Opportunities for the Antibiotic Therapy

Aleksandra Florczyk,Aleksandra Krajcer,Kinga Wójcik,Joanna Lewandowska-Łańcucka

DOI: https://doi.org/10.2147/IJN.S443051

2024-05-03

Abstract:Purpose: Surgical site infections pose a significant challenge for medical services. Systemic antibiotics may be insufficient in preventing bacterial biofilm development. With the local administration of antibiotics, it is easier to minimize possible complications, achieve drugs' higher concentration at the injured site, as well as provide their more sustained release. Therefore, the main objective of the proposed herein studies was the fabrication and characterization of innovative hydrogel-based composites for local vancomycin (VAN) therapy. Methods: Presented systems are composed of ionically gelled chitosan particles loaded with vancomycin, embedded into biomimetic collagen/chitosan/hyaluronic acid-based hydrogels crosslinked with genipin and freeze-dried to serve in a flake/disc-like form. VAN-loaded carriers were characterized for their size, stability, and encapsulation efficiency (EE) using dynamic light scattering technique, zeta potential measurements, and UV-Vis spectroscopy, respectively. The synthesized composites were tested in terms of their physicochemical and biological features. Results: Spherical structures with sizes of about 200 nm and encapsulation efficiencies reaching values of approximately 60% were obtained. It was found that the resulting particles exhibit stability over time. The antibacterial activity of the developed materials against Staphylococcus aureus was established. Moreover, in vitro cell culture study revealed that the surfaces of all prepared systems are biocompatible as they supported the proliferation and adhesion of the model MG-63 cells. In addition, we have demonstrated significantly prolonged VAN release while minimizing the initial burst effect for the composites compared to bare nanoparticles and verified their desired physicochemical features during swellability, and degradation experiments. Conclusion: It is expected that the developed herein system will enable direct delivery of the antibiotic at an exposed to infections surgical site, providing drugs sustained release and thus will reduce the risk of systemic toxicity. This strategy would both inhibit biofilm formation and accelerate the healing process.
Surface functionalization of Titania Nanotubes arrays and vancomycin controlled release using Silk Fibroin Nanofibers coating

Mehdi Fathi,Babak Akbari,Afshin Taheriazam,Arezoo Sodagar

DOI: https://doi.org/10.1016/j.jddst.2022.103320

IF: 5

2022-05-01

Journal of Drug Delivery Science and Technology

Abstract:Bacterial infections are the leading cause of failure in surgeries based on orthopedic implants. One of the promising methods to suppress bacterial infection, given the high efficiency of antibiotic administration, is to use Titania Nanotubes (Titania-NTs) loaded with antibiotics. Titania-NTs obtained by the electrochemical anodizing process have presented a modern approach in drug delivery applications. However, it is complicated to control the drug release process from drug delivery systems. This study investigates the controlled release of Vancomycin (V) from Titania-NTs surfaces enriched by drugs via physical absorption. Titania-NTs loaded with Vancomycin were coated by Silk Fibroin Nanofibers (SF-NFs). The results showed that the drug delivery was controlled through a coated layer of nanofibers. Moreover, Vancomycin inhibits bacterial development due to its antibacterial property. This is a feasible method, which enhances the viability of cells. Therefore, loading Titania-NTs with Vancomycin and using SF-NFs, as a high potential coating, can be an effective method to decrease infections after implanting orthopedic biomaterials. Drug release kinetics were calculated using different kinetic models and coefficient of determination (R2) for each model.Graphical abstractDownload : Download high-res image (141KB)Download : Download full-size image

pharmacology & pharmacy
Biologically responsive, long-term release nanocoating on an electrospun scaffold for vascular endothelialization and anticoagulation

Dongfang Wang,Xiaofeng Wang,Xuyan Li,Lin Jiang,Zhonghua Chang,Qian Li

DOI: https://doi.org/10.1016/j.msec.2019.110212

2020-02-01

Abstract:<p>A critical challenge to the development of tissue engineering small-diameter vascular grafts is to achieve rapid endothelialization and long-term anticoagulation. It is necessary to graft both adhesion and antithrombus factors onto the surface of polycaprolactone without burst release to promote endothelial cell affinity and antithrombogenicity. A bionic structure with a nanocoating that allows a biologically responsive, long-term release was employed in this work to enable the grafting of various bioactive molecules such as gelatin, polylysine, and heparin. This approach involved orienting the biomimetic vascular structures; the self-assembly grafting of gelatin, polylysine, and heparin nanoparticles; and genipin crosslinking to form a multiphase crosslinked nanocoating. In this biologically inspired design, vascular endothelialization and long-term anticoagulation were successfully induced through a matrix metallopeptidase 2 regulative mechanism by delivering both adhesion and antithrombus factors with a responsive, long-term release without burst release. The method provided a simple and effective approach for delivering dual factors for tissue engineering small-diameter vascular grafts.</p>
Silk fibroin hydrogel: A novel biopolymer for sustained release of vancomycin drug for diabetic wound healing

Vandana Singh,Deepak Kumar Tripathi,Vivek Kumar Sharma,Devika Srivastava,Umesh Kumar,Krishna Mohan Poluri,Brahma Nand Singh,Dinesh Kumar,Venkatesh Kumar R

DOI: https://doi.org/10.1016/j.molstruc.2023.135548

IF: 3.841

2023-04-26

Journal of Molecular Structure

Abstract:Diabetic wounds are a global concern due to their sluggish healing and likely to develop bacterial infections. In the current study, we prepared silk fibroin (SF) hydrogel and a composite of vancomycin (VANCO) - loaded SF hydrogel. SEM, swelling behavior, biodegradability, spreadability, viscosity analysis, infrared analysis (FTIR), and 1H NMR spectroscopy were used to characterize the composites and SF hydrogel. In addition, in vitro, in vivo, and serum analyses have been carried out. The results of SEM analysis, FTIR, and 1H NMR spectroscopy confirmed the successful encapsulation of SF hydrogel and VANCO. Whereas, in-vitro research demonstrated the controlled drug release and antibacterial ability of VANCO-loaded SF hydrogel composite. An in-vivo study revealed that a composite of VANCO-loaded SF hydrogel performed better than SF hydrogel and povidone (antiseptic cream), with diabetic wound healing percentages of 86.66, 33.33 and 16.66%, respectively. Further, serum analysis confirmed that in the composite treated group, metabolites such as lactate, serine, taurine, and others had been significantly increased, which have been directly correlated to wound healing. As a result, our composites have significant potential as antiseptic gels for diabetic wound healing.

chemistry, physical
Core-shell electrospun polycaprolactone nanofibers, loaded with rifampicin and coated with silver nanoparticles, for tissue engineering applications

Luigi Musciacchio,Mario Mardirossian,Giovanna Marussi,Matteo Crosera,Gianluca Turco,Davide Porrelli

DOI: https://doi.org/10.1016/j.bioadv.2024.214036

Abstract:In the field of tissue engineering, the use of core-shell fibers represents an advantageous approach to protect and finely tune the release of bioactive compounds with the aim to regulate their efficacy. In this work, core-shell electrospun polycaprolactone nanofiber-based membranes, loaded with rifampicin and coated with silver nanoparticles, were developed and characterized. The membranes are composed by randomly oriented nanofibers with a homogeneous diameter, as demonstrated by scanning electron microscopy (SEM). An air-plasma treatment was applied to increase the hydrophilicity of the membranes as confirmed by contact angle measurements. The rifampicin release from untreated and air-plasma treated membranes, evaluated by UV spectrophotometry, displayed a similar and constant over-time release profile, demonstrating that the air-plasma treatment does not degrade the rifampicin, loaded in the core region of the nanofibers. The presence and the distribution of silver nanoparticles on the nanofiber surface were investigated by SEM and Energy Dispersive Spectroscopy. Moreover, SEM imaging demonstrated that the produced membranes possess a good stability over time, in terms of structure maintenance. The developed membranes showed a good biocompatibility towards murine fibroblasts, human osteosarcoma cells and urotheliocytes, reveling the absence of cytotoxic effects. Moreover, doble-functionalized membranes inhibit the growth of E. coli and S. aureus. Thanks to the possibilities offered by the coaxial electrospinning, the membranes here proposed are promising for several tissue engineering applications.
Electrospinning of alginate/soy protein isolated nanofibers and their release characteristics for biomedical applications

Ratchada Wongkanya,Piyachat Chuysinuan,Chalinan Pengsuk,Supanna Techasakul,Kriengsak Lirdprapamongkol,Jisnuson Svasti,Patcharakamon Nooeaid

DOI: https://doi.org/10.1016/j.jsamd.2017.05.010

2017-09-01

Abstract:Natural polymer-based nanofibers with functions of loading and releasing bioactive cues or drugs have recently gained interest for biomedical applications. Nanotopography and large surface area to volume ratio of hydrophilic polymer fibers promote their use as carriers of hydrophilic drugs. Here, sodium alginate (SA) and soy protein isolated (SPI) blended fibers encapsulated with vancomycin were fabricated via electrospinning with the assistance of poly(ethylene oxide) (PEO). Morphological results showed submicron-sized, smooth and uniform as-spun SA/PEO/SPI fibers with an average diameter of 200 nm. Beads on the fiber mats were formed with increasing SPI content in the blending system. The optimal polymer composition of the electrospinning solution was determined as 5.6/2.4/2 SA/PEO/SPI. Polymer blends were maintained after ionic “cross-linking”, as indicated by the FTIR result. Investigation of release characteristic of vancomycin-loaded SA/PEO/SPI electrospun fibers exhibited initial burst release followed by a controlled release after 2 days of immersion in a phosphate buffered saline. The release rate of SA/PEO/SPI fibers was significantly slower than that of SA/PEO fibers, and drug-loaded fibers inhibited bacterial growth against Staphylococcus aureus after 24 h of incubation. Non-toxicity and biocompatibility of the fibers were confirmed by an indirect cytotoxicity test using human dermal fibroblasts. These results suggest that the vancomycin-loaded SA/PEO/SPI blended fibers are a promising nanomaterial for use in biomedical fields such as scaffolds for tissue engineering and drug delivery systems.

materials science, multidisciplinary,nanoscience & nanotechnology
Modulating On-Demand Release of Vancomycin from Implant Coatings via Chemical Modification of a Micrococcal Nuclease-Sensitive Oligonucleotide Linker

Jordan D. Skelly,Feiyang Chen,Shing-Yun Chang,Rewati R. Ujjwal,Ananta Ghimire,David C. Ayers,Jie Song,Jordan D Skelly,Rewati R Ujjwal,David C Ayers

DOI: https://doi.org/10.1021/acsami.3c05881

IF: 9.5

2023-08-02

ACS Applied Materials & Interfaces

Abstract:Periprosthetic infections are one of the most serious complications in orthopedic surgeries, and those caused by Staphylococcus aureus (S. aureus) are particularly hard to treat due to their tendency to form biofilms on implants and their notorious ability to invade the surrounding bones. The existing prophylactic local antibiotic deliveries involve excessive drug loading doses that could risk the development of drug resistance strains. Utilizing an oligonucleotide linker sensitive to...

materials science, multidisciplinary,nanoscience & nanotechnology
Sustainable Release of Vancomycin from Silk Fibroin Nanoparticles for Treating Severe Bone Infection in Rat Tibia Osteomyelitis Model

Negar Hassani Besheli,Fatemeh Mottaghitalab,Masoud Eslami,Mahdi Gholami,Subhas C Kundu,David L Kaplan,Mehdi Farokhi

DOI: https://doi.org/10.1021/acsami.6b14912

2017-02-15

Abstract:The successful treatment of bone infections is a major challenge in the field of orthopedics. There are some common methods for treating bone infections, including systemic antibiotic administration, local nondegradable drug vehicles, and surgical debridement, and each of these approaches has advantages and disadvantages. In the present study, the antibiotic vancomycin (VANCO) was loaded in silk fibroin nanoparticles (SFNPs) and the complexes were then entrapped in silk scaffolds to form sustained drug delivery systems. The release kinetics of VANCO from SFNPs alone and when the SFNPs were entrapped in silk scaffolds were assessed at two different pH values, 4.5 and 7.4, that affected the release profiles of VANCO. Disk diffusion tests performed with pathogens causing osteomyelitis methicillin-resistant Staphylococcus aureus (MRSA) showed antibacterial activity of the released drug at two different pH values. Additionally, injection of 8 × 106 CFU MRSA in rat's tibia induced severe osteomyelitis disease. Radiographic and histopathological analyses were performed to evaluate the effectiveness of treatment after 6 weeks. The VANCO-loaded silk fibroin nanoparticles entrapped in scaffolds reduced bone infections at the defected site with better outcomes than the other treatment groups. In conclusion, the delivery system with good biocompatibility and sustained release properties would be appropriate for further study in the context of osteomyelitis disease.
Poly (ε‐caprolactone) Coating Delays Vancomycin Delivery from Porous Chitosan/β‐tricalcium Phosphate Composites

Taolin Fang,Jianchuan Wen,Jian Zhou,Zhengzhong Shao,Jian Dong

DOI: https://doi.org/10.1002/jbm.b.32747

2012-01-01

Journal of Biomedical Materials Research Part B Applied Biomaterials

Abstract:The orthopedic infection, such as osteomyelitis, especially those caused by Methicillin-resistant Staphylococcus aureus (MRSA), remains a major complication of open fractures. Local vancomycin delivery is considered to provide better methods when avascular zones prevent the delivery of drugs from conventional routes of administration. Chitosan (CS) delivery system has been developed with the disadvantages, such as mechanically weakness, lacking osteoconductivity, and the initial burst of antibiotics into the environment. The aim of this study was to confirm that the prepared CS/β-tricalcium phosphate (β-TCP) composites coated with poly (ε-caprolactone) (PCL), similar to natural bone in components, had a three-dimensional porous structure and could be used as drug carriers to deliver vancomycin in a sustained and controlled manner effectively for 6 weeks at levels to inhibit MRSA proliferation. We prepared porous CS/β-TCP composites by incorporating β-TCP into the system, and coated the composites with PCL of three different concentrations. The morphological structure of composites, including pore size and porosity, was examined. The result showed that CS/β-TCP coated with 2.5w/v% PCL solution had the best coating effect and it retarded the release of vancomycin in a near zero-order mechanism from 0 to 14 days. The drug delivery was significantly delayed after coated with 2.5w/v% PCL. The quantitative release of vancomycin was extended to 42 days. Therefore PCL coating could be used to retard the release of vancomycin from CS/β-TCP composites in a sustained and controlled manner. Porous CS/β-TCP coated with PCL might be one of the candidate vancomycin carriers for treating MRSA-related osteomyelitis.
Barriers to nutrition care for nursing home residents.

N. Crogan,J. Shultz,Carolyn E Adams,Linda K. Massey

DOI: https://doi.org/10.3928/0098-9134-20011201-09

2001-12-01

Journal of Gerontological Nursing

Abstract:The prevalence of protein-calorie malnutrition (PCM) in nursing home residents has reached 85% in some nursing homes and is linked to increased mortality among residents. Separate survey questionnaires were developed and administered to 99 nursing assistants and 44 nurses (35 RNs, 9 LPNs) from five eastern Washington nursing homes. The purpose was to assess nurse (RN, LPN) and nursing assistant perceived beliefs and views related to nutritional needs of nursing home residents that have a potential impact on PCM of residents. Experienced nursing assistants did not view the nurse as an active participant during mealtime. Specific barriers such as a lack of time and training, too many residents, working short staffed, poor food quality, and a lack of nurse-nursing-assistant teamwork may contribute to residents not getting enough food to eat. An education program addressing staff relationships and nutrition training of nursing assistants could improve the ability of nursing staff to ensure residents' food intake and improve the quality of life for residents in nursing homes.
Incorporation of Chitosan Nanospheres into Thin Mineralized Collagen Coatings for Improving the Antibacterial Effect.

Ziqiang Kong,Mengfei Yu,Kui Cheng,Wenjian Weng,Huiming Wang,Jun Lin,Piyi Du,Gaorong Han

DOI: https://doi.org/10.1016/j.colsurfb.2013.07.006

IF: 5.999

2013-01-01

Colloids and Surfaces B Biointerfaces

Abstract:It is desired that the coatings on metallic implants have both excellent biological responses and good loading-release capacities of biological factors or drugs. So far, the challenge still remains, because the morphology and composition of the bioactive coatings are usually not favorable for accommodating drug molecules. In this study, we adopted an approach of incorporating chitosan nanospheres into a thin mineralized collagen coating; this approach is based on the good loading-release behavior of the nanospheres and the good cytocompatibility of the thin coating.The incorporation of chitosan nanospheres into the mineralized collagen coatings was realized by electrolytic co-deposition. The morphologies and microstructures of the resulting coatings were characterized by SEM, and the phase and chemical compositions of the coatings were measured by XRD and FTIR. The loading-release capacity for vancomycin hydrochloride (VH) was determined by ultraviolet spectrophotometry. MTS assay was used to evaluate cytocompatibility, and in vitro bacterial adhesion was tested for assessing the antibacterial effects of the VH-loaded coatings.The chitosan nanospheres adhered tightly to collagen fibrils. The incorporated coatings facilitated the sustained release of VH, and had a clear antibacterial effect.The incorporation of chitosan nanospheres into mineralized collagen coatings demonstrates an effective way to improve the drug loading-release capacity for the thin coatings. This formulation had a highly effective biological response. (C) 2013 Elsevier B.V. All rights reserved.
Controlled Release Mechanism of Vancomycin from Double-Layer Poly-L-Lactic Acid-Coated Implants for Prevention of Bacterial Infection

Papon Thamvasupong,Kwanchanok Viravaidya-Pasuwat

DOI: https://doi.org/10.3390/polym14173493

IF: 5

2022-08-27

Polymers

Abstract:Implantation failure due to bacterial infection incurs significant medical expenditure annually, and treatment tends to be complicated. This study proposes a method to prevent bacterial infection in implants using an antibiotic delivery system consisting of vancomycin loaded into poly-L-lactic acid (PLLA) matrices. A thin layer of this antibiotic-containing polymer was formed on stainless steel surfaces using a simple dip-coating method. SEM images of the polymeric layer revealed a honeycomb structure of the PLLA network with the entrapment of vancomycin molecules inside. In the in vitro release study, a rapid burst release was observed, followed by a sustained release of vancomycin for approximately 3 days. To extend the release time, a drug-free topcoat of PLLA was introduced to provide a diffusion resistance layer. As expected, the formulation with the drug-free topcoat exhibited a significant extension of the release time to approximately three weeks. Furthermore, the bonding strength between the double-layer polymer and the stainless steel substrate, which was an important property reflecting the quality of the coating, significantly increased compared to that of the single layer to the level that met the requirement for medical coating applications. The release profile of vancomycin from the double-layer PLLA film was best fitted with the Korsmeyer–Peppas model, indicating a combination of Fickian diffusion-controlled release and a polymer relaxation mechanism. More importantly, the double-layer vancomycin-PLLA coating exhibited antibacterial activity against S. aureus, as confirmed by the agar diffusion assay, the bacterial survival assay, and the inhibition of bacterial surface colonization without being toxic to normal cells (L929). Our results showed that the proposed antibiotic delivery system using the double-layer PLLA coating is a promising solution to prevent bacterial infection that may occur after orthopedic implantation.

polymer science
Evaluation of the In Vitro Antimicrobial Efficacy against Staphylococcus aureus and epidermidis of a Novel 3D-Printed Degradable Drug Delivery System Based on Polycaprolactone/Chitosan/Vancomycin-Preclinical Study

Iván López-González,Ana Belén Hernández-Heredia,María Isabel Rodríguez-López,David Auñón-Calles,Mohamed Boudifa,José Antonio Gabaldón,Luis Meseguer-Olmo

DOI: https://doi.org/10.3390/pharmaceutics15061763

IF: 6.525

2023-06-18

Pharmaceutics

Abstract:Acute and chronic bone infections, especially those caused by methicillin-resistant Staphylococcus aureus (MRSA), remains a major complication and therapeutic challenge. It is documented that local administration of vancomycin offers better results than the usual routes of administration (e.g., intravenous) when ischemic areas are present. In this work, we evaluate the antimicrobial efficacy against S. aureus and S. epidermidis of a novel hybrid 3D-printed scaffold based on polycaprolactone (PCL) and a chitosan (CS) hydrogel loaded with different vancomycin (Van) concentrations (1, 5, 10, 20%). Two cold plasma treatments were used to improve the adhesion of CS hydrogels to the PCL scaffolds by decreasing PCL hydrophobicity. Vancomycin release was measured by means of HPLC, and the biological response of ah-BM-MSCs growing in the presence of the scaffolds was evaluated in terms of cytotoxicity, proliferation, and osteogenic differentiation. The PCL/CS/Van scaffolds tested were found to be biocompatible, bioactive, and bactericide, as demonstrated by no cytotoxicity (LDH activity) or functional alteration (ALP activity, alizarin red staining) of the cultured cells and by bacterial inhibition. Our results suggest that the scaffolds developed would be excellent candidates for use in a wide range of biomedical fields such as drug delivery systems or tissue engineering applications.

Rapid, quantitative human lymphocyte separation and purification in a closed system.

Preparation and performance characterization of electrospun drug loaded poly (vinyl alcohol)/chitosan nanofibrous membrane

A Chitosan/gelatin/aldehyde Hyaluronic Acid Hydrogel Coating Releasing Calcium Ions and Vancomycin in Ph Response to Prevent the Formation of Bacterial Biofilm

Silk coating on poly(ε-caprolactone) microspheres for the delayed release of vancomycin.

Recurrent staphylococcal infection in a pediatric residential care facility.

In vitro drug release and antibacterial activity evaluation of silk fibroin coated vancomycin hydrochloride loaded poly (lactic-co-glycolic acid) (PLGA) sustained release microspheres

Sustainable release of vancomycin, gentamicin and lidocaine from novel electrospun sandwich-structured PLGA/collagen nanofibrous membranes

Controlled release of vancomycin from PEGylated fibrinogen polyethylene glycol diacrylate hydrogel

Innovative Vancomycin-Loaded Hydrogel-Based Systems - New Opportunities for the Antibiotic Therapy

Surface functionalization of Titania Nanotubes arrays and vancomycin controlled release using Silk Fibroin Nanofibers coating

Biologically responsive, long-term release nanocoating on an electrospun scaffold for vascular endothelialization and anticoagulation

Silk fibroin hydrogel: A novel biopolymer for sustained release of vancomycin drug for diabetic wound healing

Core-shell electrospun polycaprolactone nanofibers, loaded with rifampicin and coated with silver nanoparticles, for tissue engineering applications

Electrospinning of alginate/soy protein isolated nanofibers and their release characteristics for biomedical applications

Modulating On-Demand Release of Vancomycin from Implant Coatings via Chemical Modification of a Micrococcal Nuclease-Sensitive Oligonucleotide Linker

Sustainable Release of Vancomycin from Silk Fibroin Nanoparticles for Treating Severe Bone Infection in Rat Tibia Osteomyelitis Model

Poly (ε‐caprolactone) Coating Delays Vancomycin Delivery from Porous Chitosan/β‐tricalcium Phosphate Composites

Barriers to nutrition care for nursing home residents.

Incorporation of Chitosan Nanospheres into Thin Mineralized Collagen Coatings for Improving the Antibacterial Effect.

Controlled Release Mechanism of Vancomycin from Double-Layer Poly-L-Lactic Acid-Coated Implants for Prevention of Bacterial Infection

Evaluation of the In Vitro Antimicrobial Efficacy against Staphylococcus aureus and epidermidis of a Novel 3D-Printed Degradable Drug Delivery System Based on Polycaprolactone/Chitosan/Vancomycin-Preclinical Study